Dr. Reddy’s Laboratories Ltd

Healthcare · Drug Manufacturers - Specialty & Generic

12.50$ +2.1% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

Dr. Reddy’s Laboratories Ltd (RDY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 575,305 million INR. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of INR.

Tick rows to compare them in a chart (up to 4)

Balance Sheet RDY
Line item	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	347,022	372,842	387,518	415,297	465,955	481,059	492,989	519,537	542,005	562,899	567,877	575,305
Current Assets	217,695	238,477	248,049	269,188	248,128	253,016	250,112	269,898	279,517	297,549	295,997	299,331
Cash	13,391	7,342	7,107	4,913	11,330	12,289	14,654	9,004	9,906	18,657	15,064	11,204
Cash & Short-Term Investments	67,781	72,357	81,470	94,626	63,074	59,179	57,908	66,688	69,811	82,589	86,076	81,427
Receivables	89,693	96,078	95,338	81,088	102,840	111,494	109,792	115,443	120,841	124,269	99,215	124,417
Inventory	56,592	60,796	63,552	68,568	72,039	71,630	71,085	75,600	75,821	79,009	75,016	80,473
Property, Plant & Equipment	70,010	–	75,997	–	85,784	–	96,978	–	111,160	–	–	–
Goodwill	4,223	4,287	4,253	4,243	11,773	11,855	11,810	11,975	12,298	12,410	12,638	12,860
Intangible Assets	37,055	36,905	36,951	37,131	92,119	92,925	96,803	95,597	100,942	102,317	102,979	103,603
Total Liabilities	93,936	104,992	106,968	120,670	156,672	159,494	155,823	165,782	179,923	187,143	194,952	188,570
Current Liabilities	84,183	93,600	96,039	105,673	129,299	131,950	130,392	142,591	150,927	158,310	164,249	157,341
Short-Term Debt	7,187	13,699	14,030	24,446	41,179	43,506	38,902	43,548	46,902	56,124	63,848	60,068
Accounts Payable	30,485	31,113	21,547	34,109	35,776	36,022	20,053	37,457	40,248	40,796	32,750	37,497
Long-Term Debt	3,800	3,800	3,800	3,800	3,800	3,800	3,800	–	0.0	–	12,203	–
Shareholders' Equity	253,086	267,850	280,550	294,627	305,344	317,721	333,388	350,059	358,489	372,366	369,598	383,428
Retained Earnings	238,226	252,078	265,257	279,264	285,180	299,350	315,793	329,971	337,683	349,783	345,016	356,419
Shares Outstanding	834	167	834	834	834	834	834	833	833	833	835	833

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings